All Stories

  1. Risk Scoring System to Predict Mortality in Gastric Cancer with Peritoneal Carcinomatosis
  2. Salvage Surgery for Anal Squamous Cell Carcinoma: Still a Difficult Challenge
  3. Impact of radiotherapy on adverse events of self-expanding metallic stents in patients with esophageal cancer
  4. Underwater versus conventional EMR for nonpedunculated colorectal lesions: a randomized clinical trial
  5. Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer
  6. Results of endoscopic biliary drainage in patients with malignant hilar stricture
  7. Impact of a Routine Colorectal Endoscopic Submucosal Dissection in the Surgical Management of Nonmalignant Colorectal Lesions Treated in a Referral Cancer Center
  8. Short-Term Surgical Outcomes of Robotic Gastrectomy Compared to Open Gastrectomy for Patients with Gastric Cancer: a Randomized Trial
  9. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
  10. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
  11. Epstein-Barr Virus and PD-L1 in Esophageal and Esophagogastric Junction Cancer: Differences According to Location and Histological Type
  12. Prognostic Value of Bone Marrow Uptake Using 18F-FDG PET/CT Scans in Solid Neoplasms
  13. Effect of age on resting energy expenditure in patients with cancer
  14. Robotic-assisted versus laparoscopic incisional hernia repair: differences in direct costs from a Brazilian public institute perspective
  15. TC-325 hemostatic powder in the management of upper gastrointestinal malignant bleeding: a randomized controlled trial
  16. Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma
  17. Gastrectomy for elderly gastric cancer patients: A propensity score‐matching analysis
  18. Gastric cancer with microsatellite instability displays increased thymidylate synthase expression
  19. Multivisceral resection compared to standard gastrectomy for gastric adenocarcinoma: A propensity score‐matching analysis
  20. Preoperative chemotherapy is a better strategy than upfront surgery in cT4 gastric cancer
  21. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei
  22. Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
  23. Evaluation of the 18F-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma
  24. 18F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
  25. High dose image-guided, intensity modulated radiation therapy (IG-IMRT) for chordomas of the sacrum, mobile spine and skull base: preliminary outcomes
  26. Treatment of anastomotic leak after esophagectomy: insights of an international case vignette survey and expert discussions
  27. Tube-in-tube endoscopic vacuum therapy for the closure of upper gastrointestinal fistulas, leaks, and perforations
  28. Robotic-assisted compared with laparoscopic incisional hernia repair following oncologic surgery: short- and long-term outcomes of a randomized controlled trial
  29. SMALL BOWEL IS LARGELY AFFECTED IN BEHÇET’S DISEASE: A LONG-TERM FOLLOW-UP OF GASTROINTESTINAL SYMPTOMS
  30. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy
  31. Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma
  32. CHARACTERIZATION OF THE PSYCHOLOGICAL TYPOLOGY IN ESOPHAGEAL CANCER PATIENTS
  33. ROBOTIC-ASSISTED VERSUS LAPAROSCOPIC INCISIONAL HERNIA REPAIR: DIFFERENCES IN DIRECT COSTS FROM A BRAZILIAN PUBLIC INSTITUTE PERSPECTIVE
  34. STAGING LAPAROSCOPY IS STILL A VALUABLE TOOL FOR OPTIMAL GASTRIC CANCER MANAGEMENT
  35. Advances in surgical techniques for gastric cancer: Indocyanine green and near-infrared fluorescence imaging. Is it ready for prime time?
  36. CARNOY’S SOLUTION INCREASES LYMPH NODES COUNT IN COLON CANCER SPECIMENS WHEN COMPARED TO FORMALIN FIXATION: A RANDOMIZED TRIAL
  37. RESULTS OF SURGICAL TREATMENT OF COLORECTAL CANCER, ELECTIVE AND EMERGENCY, IN PATIENTS WITH COVID-19
  38. SURGICAL TREATMENT IN CLINICAL STAGE IV GASTRIC CANCER: A COMPARISON OF DIFFERENT PROCEDURES AND SURVIVAL OUTCOMES
  39. THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
  40. Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19
  41. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
  42. Jejunostomy in the palliative treatment of gastric cancer: A clinical prognostic score
  43. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
  44. INDOCYANINE GREEN AND NEAR-INFRARED FLUORESCENCE IMAGING IN GASTRIC CANCER PRECISION SURGICAL APPROACH
  45. Indocyanine green imaging to guide lymphadenectomy in laparoscopic distal gastrectomy - With vídeo
  46. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer
  47. Supercharged cervical anastomosis for esophagectomy and gastric pull-up
  48. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery
  49. Thoracoscopic esophagectomy is related to better outcomes in early adenocarcinoma of esophagogastric junction tumors
  50. Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study
  51. Cytotoxic T‐lymphocyte‐associated protein 4 in gastric cancer: Prognosis and association with PD‐L1 expression
  52. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score
  53. Laparoscopic Completion Total Gastrectomy for Remnant Gastric Cancer
  54. Laparoscopic gastrectomy for early and advanced gastric cancer in a western center: a propensity score-matched analysis
  55. UNDERWATER ENDOSCOPIC MUCOSAL RESECTION FOR SMALL RECTAL NEUROENDOCRINE TUMORS
  56. Epstein–Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy
  57. Remnant gastric cancer: An ordinary primary adenocarcinoma or a tumor with its own pattern?
  58. Laparoscopic transhiatal esophagectomy in esophageal cancer patients with high-risk post-operative complications
  59. Brazilian Group of Gastrointestinal Tumours’ consensus guidelines for the management of oesophageal cancer
  60. IMPACT OF AGING IN THE SURGICAL OUTCOMES OF GASTRIC CANCER PATIENTS
  61. Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era
  62. Staging Laparoscopy Is Still a Valuable Tool for Optimal Gastric Cancer Management
  63. Diagnosis of Clinical Complete Response by Probe-Based Confocal Laser Endomicroscopy (pCLE) After Chemoradiation for Advanced Rectal Cancer
  64. Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
  65. Endoscopy infection control strategy during the COVID-19 pandemic: experience from a tertiary cancer center in Brazil
  66. Impact of COVID-19 pandemic on the surgical treatment of gastric cancer
  67. Impact of telephone monitoring on cancer patients undergoing esophagectomy and gastrectomy
  68. Is it Safe to Perform Elective Colorectal Surgical Procedures during the COVID-19 Pandemic? A Single Institution Experience with 103 Patients
  69. Management of Respiratory Failure Caused by COVID-19 after Thoracoscopic Esophagectomy
  70. Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)
  71. RECURRENCE IN PN0 GASTRIC CANCER: RISK FACTORS IN THE OCCIDENT
  72. BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 2): UPDATE ON TREATMENT
  73. Common variable immunodeficiency: an important but little-known risk factor for gastric cancer
  74. CÂNCER GÁSTRICO COM EXPRESSÃO POSITIVA DO RECEPTOR DE ESTROGÊNIO ALFA: UMA SÉRIE DE CASOS DE UM ÚNICO CENTRO OCIDENTAL
  75. CIRURGIA DE RESGATE NO CÂNCER GÁSTRICO
  76. Prognostic value of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters measured in the primary tumor and suspicious lymph nodes before neoadjuvant therapy in patients with esophageal carcinoma
  77. Risk factors for adverse events of colorectal endoscopic submucosal dissection: a systematic review and meta-analysis
  78. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic
  79. Long‐term outcomes of endoscopic submucosal dissection and transanal endoscopic microsurgery for the treatment of rectal tumors
  80. D2 Lymphadenectomy According to the Arterial Variations in Gastric and Hepatic Irrigation
  81. EUS-guided gastroenterostomy: Initial experience in a brazilian tertiary center
  82. Scoring systems for PD-L1 expression and their prognostic impact in patients with resectable gastric cancer
  83. Brazilian Group of Gastrointestinal Tumours’ consensus guidelines for the management of gastric cancer
  84. Laparoscopic vs open colorectal surgery
  85. Immunohistochemical Scores for Programmed Death Ligand-1 (PD-L1) Expression and Prognostic in Patients with Gastric Cancer
  86. Remnant Gastric Cancer: Neglect Group with High Potential for Immunotherapy
  87. Delaying surgery for patients with a previous SARS-CoV-2 infection
  88. Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus
  89. Small-bowel cryptococcosis diagnosed by double-balloon endoscopy in patient without human immunodeficiency virus
  90. Remnant gastric cancer: a neglected group with high potential for immunotherapy
  91. Gastric Remnant Carcinosarcoma: Case Report and Review of the Literature
  92. Persistent postoperative ascites successfully identified and treated with laparoscopic indocyanine green fluorescence
  93. Does a history of head and neck cancer affect outcome of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma?
  94. Prognostic Value of Quantitative 18F-FDG PET/CT Parameters Measured in Primary Tumors and Suspicious Lymph Nodes in Patients with Esophageal Carcinoma.
  95. Prognostic Value of Quantitative 18F-FDG PET/CT Parameters Measured in Primary Tumors and Suspicious Lymph Nodes in Patients With Esophageal Carcinoma
  96. Underwater endoscopic resection of an ileal neuroendocrine tumor
  97. Prediction scores for complication and recurrence after multivisceral resection in gastric cancer
  98. Transhiatal laparoscopic esophagectomy with extended lymphadenectomy guided by green-indocyanine imaging for adenocarcinoma of the esophagogastric junction
  99. UNDERWATER ENDOSCOPIC MUCOSAL RESECTION FOR NON-PEDUNCULATED COLORECTAL LESIONS. A PROSPECTIVE SINGLE-ARM STUDY
  100. Safety and costs analysis of early hospital discharge after brain tumour surgery: a pilot study
  101. Validation and improvement of the predictive equation for resting energy expenditure in advanced gastrointestinal cancer
  102. Diaphragmatic Hernia Repair After Esophagectomy: Technical Report and Lessons After a Series of Cases
  103. Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma
  104. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case‐control study
  105. BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 1): AN UPDATE ON DIAGNOSIS, STAGING, ENDOSCOPIC TREATMENT AND FOLLOW-UP
  106. Cancer pain treatment during the COVID-19 pandemic: institutional recommendations
  107. Esophagectomy in a patient with pulmonary histoplasmosis: A case report of surgical aspects and complications (with video)
  108. GASTRECTOMY IN OCTOGENARIANS WITH GASTRIC CANCER: IS IT FEASIBLE?
  109. How should health systems prepare for the evolving COVID-19 pandemic? Reflections from the perspective of a Tertiary Cancer Center
  110. Impact of enteroscopy on diagnosis and management of small bowel tumors
  111. INTESTINAL PERFORATION CAUSED BY COVID-19
  112. Long-term survival analysis after endoscopic stenting as a bridge to surgery for malignant colorectal obstruction: comparison with emergency diverting colostomy
  113. Post-esophagectomy Symptomatic Dunbar Syndrome: A rare diagnosis of abdominal pain after surgery
  114. ROBOTIC GASTRECTOMY: TECHNIQUE STANDARDIZATION
  115. Surgical results of remnant gastric cancer treatment
  116. Gastric partitioning for the treatment of malignant gastric outlet obstruction
  117. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?
  118. Lymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancer
  119. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer
  120. Schistosomiasis Misleading Gastric Cancer Treatment
  121. Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients
  122. Neutrophil-lymphocyte ratio change after curative gastrectomy for gastric cancer: a subgroup analysis
  123. Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus
  124. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1
  125. LYMPHOCYTE COUNT AND PLATELET VOLUME PREDICTS POSTOPERATIVE COMPLICATIONS IN ESOPHAGECTOMY FOR CANCER: A COHORT STUDY
  126. Two-step ESD: an option for en-bloc resection of extensive colorectal laterally spreading tumors
  127. Induction Chemotherapy for Locally Advanced Esophageal Cancer
  128. Esophagojejunal anastomotic fistula: a major issue after radical total gastrectomy
  129. Su1749 ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) VERSUS TRANSANAL ENDOSCOPIC MICROSURGERY (TEM) FOR THE TREATMENT OF EARLY RECTAL CANCER: COMPARISON OF LONG TERM OUTCOMES
  130. Su1728 LONG-TERM SURVIVAL ANALYSIS AFTER ENDOSCOPIC STENTING AS A BRIDGE TO SURGERY FOR MALIGNANT COLONIC OBSTRUCTION: COMPARISON WITH EMERGENCY SURGERY
  131. Su1711 THE ROLE OF MAGNIFICATION CHROMOENDOSCOPY IN THE MANAGEMENT OF COLORECTAL NEOPLASTIC LESIONS SUSPICIOUS FOR SUBMUCOSAL INVASION
  132. Clinical and endoscopic aspects of metastases to the gastrointestinal tract
  133. The Clinical and Economic Burden of Colorectal Anastomotic Leaks: Middle-Income Country Perspective
  134. Role of Magnification Chromoendoscopy in the Management of Colorectal Neoplastic Lesions Suspicious for Submucosal Invasion
  135. Laparoscopic D2 Gastrectomy for Gastric Cancer: Mid-Term Results and Current Evidence
  136. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil
  137. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions
  138. Anatomical topography of the tumor is related to prognostic survival in adenocarcinoma of esophagogastric junction?: Multivariable analysis.
  139. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer
  140. TOTAL OMENTECTOMY IN GASTRIC CANCER SURGERY: IS IT ALWAYS NECESSARY?
  141. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study
  142. CONVERSION THERAPY FOR GASTRIC CANCER: EXPANDING THE TREATMENT POSSIBILITIES
  143. Câncer gástrico em adultos jovens: um grupo de pior prognóstico?
  144. Surgical Management of Malignant Intestinal Obstruction: Outcome and Prognostic Factors
  145. TRANSHIATAL ESOPHAGECTOMY IS NOT ASSOCIATED WITH POOR QUALITY LYMPHADENECTOMY
  146. Qualidade de vida e determinantes sociais em usuários de aparelho de amplificação sonora individual
  147. Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer
  148. Risk assessment of lymph node metastases in early gastric adenocarcinoma fulfilling expanded endoscopic resection criteria
  149. Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis Refractory to Endoscopic Treatment with Dilatation in Patients Treated for Head and Neck Cancer
  150. Probe-Based Confocal Endomicroscopy May Improve the Diagnosis of Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Neoplasia
  151. Comparison of laparoscopic versus open surgery for rectal cancer: outcomes and cost analysis
  152. The 2018 ISDE achalasia guidelines
  153. Lymph Node Yield After Neoadjuvant Chemoradiotherapy in Rectal Cancer Specimens: A Randomized Trial Comparing Two Fixatives
  154. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision
  155. Analysis of the expansion of supply and demand of Speech-Language Pathology/Audiology courses in Brazil between 1994 and 2014
  156. Risk factors associated with the development of gastric cancer — case-control study
  157. Reply to: “Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer”
  158. HEALTH-RELATED QUALITY OF LIFE ASSESSMENT IN PATIENTS WITH RECTAL CANCER TREATED WITH CURATIVE INTENT
  159. Effect of postoperative goal-directed therapy in cancer patients undergoing high-risk surgery: a randomized clinical trial and meta-analysis
  160. Predictors of major complications after elective abdominal surgery in cancer patients
  161. Duodenal fistula: The most lethal surgical complication in a case series of radical gastrectomy
  162. Risk factors for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis: a prospective, single-center study
  163. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer
  164. Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer
  165. Variables Associated to Pathologic Complete Response, Overall Survival and Disease-Free Survival in the Neoadjuvant Setting for Esophageal Cancer: A Retrospective Cohort Analysis
  166. Advanced age does not increase morbidity in pancreaticoduodenectomy
  167. Self-expandable metal stent for malignant esophagorespiratory fistula: predictive factors associated with clinical failure
  168. Comparative study of transhiatal and transthoracic thoracoscopic esophagectomy results in adenocarcinoma of the esophagogastric junction.
  169. Comparing the Performance of Ground Filtering Algorithms for Terrain Modeling in a Forest Environment Using Airborne LiDAR Data
  170. Surgical treatment of gastric cancer: a 10-year experience in a high-volume university hospital
  171. Validation of classic and expanded criteria for endoscopic submucosal dissection of early gastric cancer: 7 years of experience in a Western tertiary cancer center
  172. Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy
  173. Probe-based confocal endomicroscopy is accurate for differentiating gastric lesions in patients in a Western center
  174. Prognostic Role of Neutrophil/Lymphocyte Ratio in Resected Gastric Cancer: A Systematic Review and Meta-analysis
  175. Liquid phase sintering of ferrite of NiCuZn with low magnetic permeability for miniaturization
  176. Early mobilization programme improves functional capacity after major abdominal cancer surgery: a randomized controlled trial
  177. Clinicopathological Characteristics and Prognostic Value of Epstein-Barr Virus-associated Gastric Cancer, Microsatellite Instability and PD-L1 Immunoexpression
  178. Colonoscopic Findings in Patients With Positive Fecal Immunochemical Test During a Pilot Study of Colorectal Cancer Screening in a Western Country: Partial Results
  179. Robotic Oncological Surgery Program Evaluation Using A Logic Model
  180. CHARACTERIZATION OF THE MUCIN PHENOTYPE CAN PREDICT GASTRIC CANCER RECURRENCE AFTER ENDOSCOPIC MUCOSAL RESECTION
  181. Erratum to: One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer
  182. Outcomes of Immediate Internal Pudendal Artery Perforator Flap Reconstruction for Irradiated Abdominoperineal Resection Defects
  183. One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer
  184. Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease
  185. Cyclooxygenase-2 gene polymorphisms and susceptibility to colorectal cancer in a Brazilian population
  186. Hand-assisted Approach as a Model to Teach Complex Laparoscopic Hepatectomies: Preliminary Results
  187. Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment
  188. Diagnostic accuracy of probe-based confocal laser endomicroscopy in Lugol-unstained esophageal superficial lesions of patients with head and neck cancer
  189. GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE
  190. Integrated care pathway for rectal cancer treatment
  191. Efficacy of 3-Dimensional Endorectal Ultrasound for Staging Early Extraperitoneal Rectal Neoplasms
  192. Mo1082 Clinical and Endoscopic Features of Metastases to the Gastrointestinal Tract
  193. Tu1229 Clinical Outcomes of Endoscopic Submucosal Dissection for Superficial Esophageal Neoplasms of Patients With Head and Neck Cancer
  194. Sa1728 Underwater Endoscopic Mucosal Resection for Non-Pendulated Colorectal Lesions. Is the Distal Cap Really Necessary?
  195. Mo1187 Validation of Classic and Expanded Criteria for Endoscopic Submucosal Dissection of Early Gastric Cancer: 7 Years of Experience of a Western Tertiary Cancer Center
  196. Comparison of the pull and introducer percutaneous endoscopic gastrostomy techniques in patients with head and neck cancer
  197. Lymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status
  198. Outcome of Gastric Cancer Patients Submitted to D1 Lymph Node Dissection Due to Unfavorable Medical Conditions
  199. Predictors of Pathological Tumor Response in Gastric Cancer Patients after Neoadjuvant Therapy
  200. Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer after Optimal Surgical Treatment
  201. DETECTION OF OCCULT LYMPH NODE TUMOR CELLS IN NODE-NEGATIVE GASTRIC CANCER PATIENTS
  202. Predictors of pathological response and tumor regression following neoadjuvant therapy in advanced gastric cancer patients.
  203. Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group
  204. Prognostic factors affecting outcomes in multivisceral en bloc resection for colorectal cancer
  205. Polymorphisms in the cyclooxygenase-2 (COX-2) gene, vascular endothelial growth factor (VEGF) and methylenetetrahydrofolate reductase (MTHFR) gene in patients with hepatocellular carcinoma and hepatitis C virus infection
  206. Understanding the factors associated with reduction in the number of lymph nodes in rectal cancer patients treated by neoadjuvant treatment
  207. EVALUATION OF LYMPHATIC SPREAD, VISCERAL METASTASIS AND TUMORAL LOCAL INVASION IN ESOPHAGEAL CARCINOMAS
  208. PROGNOSTIC FACTORS AND SURVIVAL ANALYSIS IN ESOPHAGEAL CARCINOMA
  209. MINIMALLY INVASIVE SURGERY FOR GASTRIC CANCER: TIME TO CHANGE THE PARADIGM
  210. Evaluation of an Integrated Care Pathway for Rectal Cancer Treatment Implementation Using a Logic Model
  211. Tu1205 Esophagorespiratory Fistulas Related to the Placement of Self-Expanding Metallic Stents for the Treatment of Malignant Esophageal Disphagia
  212. Tu1208 Patency and Complications of Self-expandable Esophageal Metallic Stents in Patients with Advanced Malignant Disease and long term survival
  213. Tu1198 Predictive Factors of Clinical Failure After Endoscopic Stenting of Malignant Esophagorespiratory Fistulas
  214. Pathologic Complete Response in Rectal Cancer
  215. ESOPHAGEAL CARCINOMA: IS SQUAMOUS CELL CARCINOMA DIFFERENT DISEASE COMPARED TO ADENOCARCINOMA? A transversal study in a quaternary high volume hospital in Brazil
  216. Obscure gastrointestinal bleeding caused by intestinal lipomatosis: double-balloon endoscopic and laparoscopic views
  217. Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course
  218. Argon plasma coagulation for the endoscopic treatment of gastrointestinal tumor bleeding: A retrospective comparison with a non‐treated historical cohort
  219. Prospective results of perioperative chemotherapy (PCT) with cisplatin and irinotecan for locally advanced gastric cancer.
  220. Predicting recurrence after curative resection for gastric cancer
  221. Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis
  222. Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma
  223. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients
  224. Underwater endoscopic resection of a neuroendocrine rectal tumor
  225. Endoscopic stent for treatment of esophagojejunostomy fistula
  226. Endoscopic radial incision and cutting procedure for a colorectal anastomotic stricture
  227. Frequency of CDH1 germline mutations in diffuse gastric cancer in Brazil.
  228. Sa1561 Magnifying Chromoendoscopy Is Decisive to Define Management of Colorectal Neoplastic Lesions
  229. Su1714 Prediction of Histology by Confocal LASER Endomicroscopy in Lugol-Unstained Esophageal Superficial Lesions of Patients With Head and Neck Cancer
  230. Sa1643 Self-Expanding Metallic Stents for the Treatment of Malignant Colorectal Obstruction Are Effective and Safe
  231. Primary malignant melanoma of the esophagus
  232. Transfusion Requirements in Surgical Oncology Patients
  233. Endoscopic hemostasis of a bleeding gastric gastrointestinal stromal tumor (GIST) with endoloop placement
  234. Gastrointestinal stromal tumor of the rectum treated with neoadjuvant Imatinib followed by transanal endoscopic microsurgery
  235. Palliative laparoscopic resection of renal cell carcinoma metastatic to the stomach: report of a case
  236. Carnoy’s solution increases the number of examined lymph nodes following gastrectomy for adenocarcinoma: a randomized trial
  237. Carnoy's solution is an adequate tissue fixative for routine surgical pathology, preserving cell morphology and molecular integrity
  238. Comparing different strategies for the allocation of improvement programmes in a flow shop environment
  239. Simplified technique for reconstruction of the digestive tract after total and subtotal gastrectomy for gastric cancer
  240. Asymptomatic Gastric Bacterial Overgrowth After Bariatric Surgery: Are Long-Term Metabolic Consequences Possible?
  241. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma
  242. Liver Irradiation Increases Relapse-Free Survival in Adjuvant Gastric Cancer Treatment
  243. Cirurgia abdominal por robótica: experiência brasileira inicial
  244. Primary malignant melanoma of the esophagus: a rare and aggressive disease
  245. Percutaneous Transhepatic Biliary Drainage in Patients with Advanced Solid Malignancies: Prognostic Factors and Clinical Outcomes
  246. Epithelial Cell Turnover Is Increased in the Excluded Stomach Mucosa After Roux-en-Y Gastric Bypass for Morbid Obesity
  247. MOLECULAR MARKERS OF MUCOSA HARBORING GASTRIC ADENOMAS
  248. Abstract 4845: VEGF-A and Cox-2 gene polymorphisms and susceptibility to colorectal cancer in Brazilian population.
  249. Etiology, endoscopic management and mortality of upper gastrointestinal bleeding in patients with cancer
  250. Resultados da gastrectomia D2 para o câncer gástrico: dissecção da cadeia linfática ou ressecção linfonodal múltipla?
  251. A novel approach for the treatment of pelvic abscess: transrectal endoscopic drainage facilitated by transanal endoscopic microsurgery access
  252. Endoscopic removal of migrated esophageal stent - the “grasper and pusher” method
  253. Isolated splenic metastasis from lung squamous cell carcinoma
  254. Excisão total do mesorreto por laparoscopia
  255. Método laparoscópico no diagnóstico e extensão da carcinomatose peritoneal
  256. Squamous Cell Carcinoma and Neuroendocrine Carcinoma Colliding in the Esophagus
  257. Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions
  258. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
  259. Gastric secretory and hormonal patterns in end-stage chagasic achalasia
  260. Preoperative Gastric Acid Secretion and the Risk to Develop Barrett’s Esophagus After Esophagectomy for Chagasic Achalasia
  261. Barrett’s Esophagus and Carcinoma in the Esophageal Stump After Esophagectomy for Achalasia
  262. Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study
  263. Carnoy’s solution enhances lymph node detection: an anatomical dissection study in cadavers
  264. Single-use Trocar
  265. The controversial role of tumor necrosis factor α in fibrotic diseases
  266. Barrett’s Esophagus (BE) and Carcinoma in the Esophageal Stump (ES) After Esophagectomy with Gastric Pull-Up in Achalasia Patients: A Study Based on 10 Years Follow-Up
  267. Secondary Lymphangiectasia of the Small Bowel: Utility of Double Balloon Enteroscopy for Diagnosis and Management
  268. Análise de fatores clínicos e histopatológicos em metástases hepáticas de adenocarcinoma colorretal
  269. Caffeic Acid Phenethyl Ester (CAPE) May be a Promising Adjuvant Treatment in Gastric Cancer
  270. Is double-balloon enteroscopy an accurate method to diagnose small-bowel disorders?
  271. Immunohistochemistry Panel of Early Gastric Cancer Can Predict Recurrence After Endoscopic Mucosal Resection
  272. Clinicopathologic and Immunohistochemistry Characterization of Synchronous Multiple Primary Gastric Adenocarcinoma
  273. What to Expect in the Excluded Stomach Mucosa after Vertical Banded Roux-en-Y Gastric Bypass for Morbid Obesity
  274. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors
  275. Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma (Br J Surg 2006; 93: 325 –331)
  276. Does CO2 Pneumoperitoneum Alter the Ultra-Structuture of the Mesothelium?
  277. p53 na prática clínica: sim ou não?
  278. Does the Intraoperative Peritoneal Lavage Cytology Add Prognostic Information in Patients With Potentially Curative Gastric Resection?
  279. Interleukin-2-Activated Natural Killer Cells May Have a Direct Role in the Control of Leishmania (Leishmania) amazonensis Promastigote and Macrophage Infection.
  280. Cytotoxicity, genotoxicity and antimutagenicity of hexane extracts of Agaricus blazei determined in vitro by the comet assay and CHO/HGPRT gene mutation assay
  281. Does Socioeconomic Status Influence the Prevalence of Early Gastric Cancer?
  282. Molecular Markers in Mucosa Harboring Gastric Adenomas
  283. Reflux Esophagitis and Ectopic Columnar Epithelium (Barrett's Esophagus) in the Esophageal Stump after Cervical Gastroplasty
  284. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival
  285. Complications of gastrectomy with lymphadenectomy in gastric cancer
  286. Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy
  287. Participação da apoptose na rejeição aguda do transplante intestinal em ratos
  288. Estudo das alterações das citocinas inflamatórias na rejeição aguda do transplante intestinal em ratos
  289. Microsatellite instability in solitary and sporadic gastric cancer
  290. Immunohistochemistry in the evaluation of response and prognosis in distal rectal cancer patients treated by neo-adjuvant radio/chemotherapy
  291. VEGF immunoexpression is associated with increased microvascular density and tumor invasiveness in gastric adenocarcinoma
  292. Gastric stump mucosa: is there a risk for carcinoma?
  293. Cell-mediated immune response in megacolon from patients with chronic chagas' disease
  294. Long-term Survival Following Induction Chemoradiotherapy and Esophagectomy for Esophageal Carcinoma
  295. Does the congestive gastropathy influence Helicobacter pylori infection?
  296. New UICC TNM staging system for gastric cancer: Is there any improvement in prognostication?
  297. Prognostic value of p53 and Ki67 expression in gastric carcinoid tumors
  298. Value of immunohistochemistry in detecting intraperitoneal free cancer cells from washings in patients with colorectal carcinoma
  299. 4758 Gastrin is expressed in jejunum biopsies of postgastrectomy patients.
  300. Low rectal cancer: Value of CD34 and CEA expression following multimodality therapy
  301. P53 overexpression is associated with increased risk of malignancy in the megaesophagus but it is not present in megacolon due to chagas’ disease
  302. Squamous cell carcinoma of the esophagus and multiple primary tumors of the upper aerodigestive tract
  303. Double pylorus: case report and review of the literature
  304. Activated Natural Killer Cell Tumor Retention and Cytokine Production in Colon Tumor Using a Tissue-Isolated Model
  305. Relationship Between Persistence of Helicobacter pylori and Dysplasia, Intestinal Metaplasia, Atrophy, Inflammation, and Cell Proliferation Following Partial Gastrectomy
  306. Effect of chagas' disease on nitric oxide-containing neurons in severely affected and unaffected intestine
  307. Apoptosis In Esophageal Cancer Following Induction Chemoradiotherapy
  308. Low rectal cancer
  309. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma
  310. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma
  311. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer
  312. Gastric Stump Cancer: What Is the Risk?
  313. Role of Nutrition Support During Induction Chemoradiation Therapy in Esophageal Cancer
  314. Is Esophagectomy Following Upfront Chemoradiotherapy Safe and Necessary?
  315. Risk factors for squamous cell carcinoma of the oesophagus
  316. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach
  317. Risk factors for squamous cell carcinoma of the oesophagus
  318. Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract
  319. P53 expression and mutation differs between adenocarcinoma of the gastroesophageal junction and gastric antrum
  320. Laparoscopic Removal of a Displaced Ventriculoperitoneal Shunt